Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Viking Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
04:05pm, Wednesday, 07'th Apr 2021
SAN DIEGO, April 7, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic an
Viking Therapeutics' (VKTX) CEO Brian Lian on Q4 2020 Results - Earnings Call Transcript
08:33pm, Wednesday, 17'th Feb 2021
Viking Therapeutics' (VKTX) CEO Brian Lian on Q4 2020 Results - Earnings Call Transcript
Viking Therapeutics Announces Senior Management Team Appointments
04:05pm, Wednesday, 06'th Jan 2021
SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and
Viking Therapeutics: Progressing Steadily, But Concerns Remain
07:09am, Sunday, 29'th Nov 2020
The entire NASH space was shaken by Genfit's trial fiasco; Viking has its own problems. The drug may actually be a wonderful new therapy for NASH/NAFLD patients; however, whether VKTX will benefit fro
3 Stocks with Jaw-Dropping Growth Potential
10:00am, Monday, 23'rd Nov 2020
Aprea Therapeutics, Viking Therapeutics, and Vaxart could all generate life-changing returns for early shareholders.
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2020 Results - Earnings Call Transcript
11:05pm, Wednesday, 28'th Oct 2020
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2020 Results - Earnings Call Transcript
